PLX

Protalix Biotherapeutics, Inc.

A biopharmaceutical company based in Israel, Protalix makes medicines for rare diseases by growing therapeutic proteins in plant cells. Its signature product, Elelyso, treats Gaucher disease and was the first plant-cell-made protein the FDA ever approved, developed with Pfizer. Founded in 1993 by a plant biochemist, the company grows engineered carrot cells as living bioreactors instead of animal cells.

CUSIP: 74365A1011 holder

Ownership Activity Financials Filings

PLX

PLX

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Regulation FD Disclosure

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Other Events

Regulation FD Disclosure

Other Events